|
Name |
Phomalone
|
Molecular Formula | C13H18O5 | |
IUPAC Name* |
1-[2,4-dihydroxy-3-(2-hydroxyethyl)-6-methoxyphenyl]butan-1-one
|
|
SMILES |
CCCC(=O)C1=C(C=C(C(=C1O)CCO)O)OC
|
|
InChI |
InChI=1S/C13H18O5/c1-3-4-9(15)12-11(18-2)7-10(16)8(5-6-14)13(12)17/h7,14,16-17H,3-6H2,1-2H3
|
|
InChIKey |
PTBQWWHUOMDVFS-UHFFFAOYSA-N
|
|
Synonyms |
Phomalone; 159768-89-5; 1-[2,4-dihydroxy-3-(2-hydroxyethyl)-6-methoxyphenyl]butan-1-one; 1-(2,4-Dihydroxy-3-(2-hydroxyethyl)-6-methoxyphenyl)butan-1-one; DTXSID10166722; CHEBI:182590; ZINC5819671; Phomalone, >=95% (LC/MS-UV); 1-Butanone, 1-(2,4-dihydroxy-3-(2-hydroxyethyl)-6-methoxyphenyl)-; NCGC00381307-01!1-[2,4-dihydroxy-3-(2-hydroxyethyl)-6-methoxyphenyl]butan-1-one
|
|
CAS | 159768-89-5 | |
PubChem CID | 178026 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 254.28 | ALogp: | 1.8 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 87.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 18 | QED Weighted: | 0.677 |
Caco-2 Permeability: | -4.724 | MDCK Permeability: | 0.00001060 |
Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0.016 |
Human Intestinal Absorption (HIA): | 0.274 | 20% Bioavailability (F20%): | 0.555 |
30% Bioavailability (F30%): | 0.658 |
Blood-Brain-Barrier Penetration (BBB): | 0.183 | Plasma Protein Binding (PPB): | 64.66% |
Volume Distribution (VD): | 1.065 | Fu: | 28.85% |
CYP1A2-inhibitor: | 0.835 | CYP1A2-substrate: | 0.889 |
CYP2C19-inhibitor: | 0.057 | CYP2C19-substrate: | 0.383 |
CYP2C9-inhibitor: | 0.093 | CYP2C9-substrate: | 0.807 |
CYP2D6-inhibitor: | 0.174 | CYP2D6-substrate: | 0.487 |
CYP3A4-inhibitor: | 0.06 | CYP3A4-substrate: | 0.187 |
Clearance (CL): | 13.073 | Half-life (T1/2): | 0.882 |
hERG Blockers: | 0.029 | Human Hepatotoxicity (H-HT): | 0.051 |
Drug-inuced Liver Injury (DILI): | 0.659 | AMES Toxicity: | 0.309 |
Rat Oral Acute Toxicity: | 0.092 | Maximum Recommended Daily Dose: | 0.017 |
Skin Sensitization: | 0.738 | Carcinogencity: | 0.038 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.696 |
Respiratory Toxicity: | 0.212 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002568 | 0.755 | D0WY9N | 0.320 | ||||
ENC002881 | 0.450 | D03LGG | 0.267 | ||||
ENC005954 | 0.443 | D0U5CE | 0.267 | ||||
ENC001513 | 0.383 | D08VYV | 0.259 | ||||
ENC004096 | 0.379 | D07MEH | 0.256 | ||||
ENC004983 | 0.377 | D0Y6KO | 0.253 | ||||
ENC002781 | 0.375 | D0O1UZ | 0.247 | ||||
ENC005636 | 0.362 | D08EVN | 0.244 | ||||
ENC004428 | 0.356 | D0U0OT | 0.239 | ||||
ENC000507 | 0.350 | D0E9CD | 0.238 |